Skip to content
2000
Volume 4, Issue 1
  • ISSN: 2666-8629
  • E-ISSN: 2666-8637

Abstract

The incidence of Psoriasis has been recorded as around 125 million cases worldwide, which comprises of around 2-3% of the general population throughout the globe. Major complications coupled with the disease comprise of psoriatic arthritis, depression, and cardio syndrome, leading to compromised palliation of aggravated depreciation of Health. Contemporary strategies intervene only in symptomatic relief without complete cure and occasionally even lead to skin melanoma. Henceforth, this compilation reviews the diverse clinical features of this skin disease and discusses relevant therapeutic strategies and outcomes therein.

An accumulated amount of evidence was obtained relevant keywords from authentic databases . Web of Science, Science direct, and Scopus. A comprehensive exploration unveiled an imperative role of plant-derived therapeutics in combating side effects related to synthetic drugs. The data also exhibited an association between synthetic and natural alternatives where the role of combination strategies is indispensable, deduced by both and research. The clinical trial data also appeared to be encouraging with respect to herb-induced treatment and prevention of Psoriasis.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cff/10.2174/0126668629317880250219052526
2025-03-05
2025-10-21

  • From This Site

    /content/journals/cff/10.2174/0126668629317880250219052526
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. RendonA. SchäkelK. Psoriasis pathogenesis and treatment.Int. J. Mol. Sci.2019206147510.3390/ijms20061475 30909615
     [Google Scholar]
  2. LevineD. GottliebA. Evaluation and management of psoriasis: An internist’s guide.Med. Clin. North Am.20099361291130310.1016/j.mcna.2009.08.003 19932332
     [Google Scholar]
  3. KimW.B. JeromeD. YeungJ. Diagnosis and management of psoriasis.Can. Fam. Physician2017634278285 28404701
     [Google Scholar]
  4. PappK GulliverW LyndeC PoulinY AshkenasJ Canadian Psoriasis Guidelines CommitteeCanadian guidelines for the management of plaque psoriasis: OverviewJ Cutan Med Surg201115421021910.2310/7750.2011.1006621781627
     [Google Scholar]
  5. RaharjaA. MahilS.K. BarkerJ.N. Psoriasis: A brief overview.Clin. Med. (Lond.)202121317017310.7861/clinmed.2021‑0257 34001566
     [Google Scholar]
  6. LeeS.E. LewW. The increased expression of matrix metalloproteinase-9 messenger RNA in the non-lesional skin of patients with large plaque psoriasis vulgaris.Ann. Dermatol.2009211273410.5021/ad.2009.21.1.27 20548851
     [Google Scholar]
  7. FitzgeraldT. ZhdanavaM. PilonD. Long-term psoriasis control with guselkumab, adalimumab, secukinumab, or ixekizumab in the USA.Dermatol. Ther. (Heidelb.)20231341053106810.1007/s13555‑023‑00910‑6 36929120
     [Google Scholar]
  8. KoH.C. JwaS.W. SongM. KimM.B. KwonK.S. Clinical course of guttate psoriasis: Long‐term follow‐up study.J. Dermatol.2010371089489910.1111/j.1346‑8138.2010.00871.x 20860740
     [Google Scholar]
  9. MartinB.A. ChalmersR.J. TelferN.R. How great is the risk of further psoriasis following a single episode of acute guttate psoriasis?Arch. Dermatol.1996132671771810.1001/archderm.1996.03890300147032 8651734
     [Google Scholar]
  10. SyedZ.U. KhachemouneA. Inverse psoriasis.Am. J. Clin. Dermatol.201112214314610.2165/11532060‑000000000‑00000 21184623
     [Google Scholar]
  11. ViguierM. PagèsC. AubinF. Efficacy and safety of biologics in erythrodermic psoriasis: A multicentre, retrospective study.Br. J. Dermatol.2012167241742310.1111/j.1365‑2133.2012.10940.x 22413927
     [Google Scholar]
  12. HawiloA. ZaraaI. BenmouslyR. Erythrodermic psoriasis: Epidemiological clinical and therapeutic features about 60 cases.Tunis. Med.20118911841847 22179920
     [Google Scholar]
  13. AydinS.Z. Castillo-GallegoC. AshZ.R. Potential use of optical coherence tomography and high-frequency ultrasound for the assessment of nail disease in psoriasis and psoriatic arthritis.Dermatology20132271455110.1159/000351702 23988587
     [Google Scholar]
  14. LangleyR.G.B. KruegerG.G. GriffithsC.E. Psoriasis: Epidemiology, clinical features, and quality of life.Ann. Rheum. Dis.200564Suppl. 2ii18ii2310.1136/ard.2004.033217 15708928
     [Google Scholar]
  15. KumarD. RajguruJ.P. MayaD. SuriP. BhardwajS. PatelN. Update on psoriasis: A review.J. Family Med. Prim. Care202091202410.4103/jfmpc.jfmpc_689_19 32110559
     [Google Scholar]
  16. BrandonA. MuftiA. Gary SibbaldR. Diagnosis and management of cutaneous psoriasis: A review.Adv. Skin Wound Care2019322586910.1097/01.ASW.0000550592.08674.43 30653184
     [Google Scholar]
  17. ArmstrongA.W. ReadC. Pathophysiology, clinical presentation, and treatment of psoriasis: A review.JAMA2020323191945196010.1001/jama.2020.4006
     [Google Scholar]
  18. TanewA. GuggenbichlerA. HönigsmannH. GeigerJ.M. FritschP. Photochemotherapy for severe psoriasis without or in combination with acitretin: A randomized, double-blind comparison study.J. Am. Acad. Dermatol.199125468268410.1016/0190‑9622(91)70253‑X 1838750
     [Google Scholar]
  19. LoweN.J. PrystowskyJ.H. BourgetT. EdelsteinJ. NychayS. ArmstrongR. Acitretin plus UVB therapy for psoriasis.J. Am. Acad. Dermatol.199124459159410.1016/0190‑9622(91)70089‑K 1827799
     [Google Scholar]
  20. LyndeC.W. GuptaA.K. GuentherL. PoulinY. LevesqueA. BissonnetteR. A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept.J. Dermatolog. Treat.201223426126710.3109/09546634.2011.607795 21797805
     [Google Scholar]
  21. WolfP. WegerW. LegatF.J. Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: A randomized intraindividual trial.Br. J. Dermatol.2012166114715310.1111/j.1365‑2133.2011.10616.x 21910714
     [Google Scholar]
  22. MahajanR. KaurI. KanwarA.J. Methotrexate/narrowband UVB phototherapy combination vs. narrowband UVB phototherapy in the treatment of chronic plaque‐type psoriasis – a randomized single‐blinded placebo‐controlled study.J. Eur. Acad. Dermatol. Venereol.201024559560010.1111/j.1468‑3083.2009.03486.x 20015056
     [Google Scholar]
  23. Al-HamamyH.R. Al-MashhadaniS.A. MustafaI.N. Comparative study of the effect of narrowband ultraviolet B phototherapy plus methotrexate vs. narrowband ultraviolet B alone and methotrexate alone in the treatment of plaque‐type psoriasis.Int. J. Dermatol.201453121531153510.1111/ijd.12444 24738793
     [Google Scholar]
  24. ZachariaeC. MørkN. ReunalaT. The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy.Acta Derm. Venereol.200888549550110.2340/00015555‑0511 18779890
     [Google Scholar]
  25. GottliebA.B. LangleyR.G. StroberB.E. A randomized, double‐blind, placebo‐controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis.Br. J. Dermatol.2012167364965710.1111/j.1365‑2133.2012.11015.x 22533447
     [Google Scholar]
  26. YuQ. TongY. CuiL. Efficacy and safety of etanercept combined plus methotrexate and comparison of expression of pro-inflammatory factors expression for the treatment of moderate-to-severe plaque psoriasis.Int. Immunopharmacol.20197344245010.1016/j.intimp.2019.05.042 31154289
     [Google Scholar]
  27. AtzeniF. BoccassiniL. AntivalleM. SalaffiF. Sarzi-PuttiniP. Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis: A randomised pilot study.Ann. Rheum. Dis.201170471271410.1136/ard.2010.130864 20810394
     [Google Scholar]
  28. LeeJ.H. YounJ.I. KimT.Y. A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in patients with moderate to severe psoriasis.BMC Dermatol.20161611110.1186/s12895‑016‑0048‑z 27455955
     [Google Scholar]
  29. BagelJ. NelsonE. KeeganB.R. Apremilast and narrowband ultraviolet-b combination therapy for treating moderate-to-severe plaque psoriasis.J. Drugs Dermatol.20171610957962 29036248
     [Google Scholar]
  30. LebwohlM. Acitretin in combination with UVB or PUVA.J. Am. Acad. Dermatol.1999413S22S2410.1016/S0190‑9622(99)70362‑2 10459143
     [Google Scholar]
  31. WeisenseelP. ReichK. GriembergW. Efficacy and safety of fumaric acid esters in combination with phototherapy in patients with moderate‐to‐severe plaque psoriasis (FAST).J. Dtsch. Dermatol. Ges.201715218018610.1111/ddg.12837
     [Google Scholar]
  32. AbuHilalM. WalshS. ShearN. Use of apremilast in combination with other therapies for treatment of chronic plaque psoriasis: A retrospective study.J. Cutan. Med. Surg.201620431331610.1177/1203475416631328 26848145
     [Google Scholar]
  33. NarangT. KumarS. HandaS. DograS. Hydroxyurea and acitretin as a novel combination therapy in severe plaque psoriasis.Br. J. Dermatol.201817951212121310.1111/bjd.16899 29927478
     [Google Scholar]
  34. JaneczekM. MoyL. LakeE.P. SwanJ. Review of the efficacy and safety of topical Mahonia aquifolium for the treatment of psoriasis and atopic dermatitis.J. Clin. Aesthet. Dermatol.201811124247 30666279
     [Google Scholar]
  35. ZhuB. JiangM. YuQ. GeX. YuanF. ShiL. Treatments in psoriasis from standard pharmacotherapy to nanotechnology therapy.Postepy Dermatol. Alergol.202239346047110.5114/ada.2021.108445 35950130
     [Google Scholar]
  36. HarshaT.L. TejaswiniK.S. NischithS.S. Rupesh HumarM.M. BharathiD.R. AhmedS.S. Phytopharmaceutical and pharmacological aspects of “Pongamia pinnata”: A comprehensive review.Int J Heal Care Biolog Sci20226384410.46795/ijhcbs.v3i2.325
     [Google Scholar]
  37. KumarA. PN. KumarM. Major phytochemicals: Recent advances in health benefits and extraction method.Molecules202328288710.3390/molecules28020887 36677944
     [Google Scholar]
  38. TaylorE.J. Evaluation of medicinal plants used in the treatment of psoriasis.United KingdomUniversity of London1999
     [Google Scholar]
  39. ElkhawagaO.Y. ElletyM.M. MoftyS.O. GhanemM.S. MohamedA.O. Review of natural compounds for potential psoriasis treatment.Inflammopharmacology20233131183119810.1007/s10787‑023‑01178‑0 36995575
     [Google Scholar]
  40. MasonA.R. MasonJ. CorkM. DooleyG. HancockH. Topical treatments for chronic plaque psoriasis.Cochrane Database Syst. Rev.201320133CD00502810.1002/14651858.CD005028.pub3 23543539
     [Google Scholar]
  41. NiliusB. AppendinoG. Spices: the savory and beneficial science of pungency.Rev. Physiol. Biochem. Pharmacol.201316417610.1007/112_2013_11 23605179
     [Google Scholar]
  42. ChengH.M. WuY.C. WangQ. Clinical efficacy and IL-17 targeting mechanism of Indigo naturalis as a topical agent in moderate psoriasis.BMC Complement. Altern. Med.201717143910.1186/s12906‑017‑1947‑1 28865459
     [Google Scholar]
  43. LinY.K. LeuY.L. YangS.H. ChenH.W. WangC.T. PangJ.H.S. Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component.J. Dermatol. Sci.200954316817410.1016/j.jdermsci.2009.02.007 19303259
     [Google Scholar]
  44. KimS.J. JangY.W. HyungK.E. Therapeutic effects of methanol extract from Euphorbia kansui radix on Imiquimod‐induced psoriasis.J. Immunol. Res.20172017111710.1155/2017/7052560 28761880
     [Google Scholar]
  45. DwarampudiL.P.S.P.D. FarhaS. GadeR. Phytochemical evaluation and anti-psoriatic activity of the ethanolic extract of the leaves of Momordica charantia.Indian J. Biochem. Biophys.2022597751754
     [Google Scholar]
  46. VijayalakshmiA. GeethaM. RavichandiranV. Quantitative evaluation of the antipsoriatic activity of flavonoids from Cassia tora Linn. leaves. Iranian J Sci Tech, Transactions A.Science201741307312
     [Google Scholar]
  47. BacanliM. ErdoğanH. Treating autoimmune diseases using phytonanotechnology.In: Advances in Phytonanotechnology for Treatment of Various Diseases.1st edBoca Raton, FLCRC Press202321523810.1201/9781003231721‑9
     [Google Scholar]
  48. MurugananthamN. BasavarajK.H. DhanabalS.P. PraveenT.K. ShamasundarN.M. RaoK.S. Screening of Caesalpinia bonduc leaves for antipsoriatic activity.J. Ethnopharmacol.2011133289790110.1016/j.jep.2010.09.026 20920562
     [Google Scholar]
  49. BhoirS.S. VishwapathiV. SinghK.K. Antipsoriatic potential of Annona squamosa seed oil: An in vitro and in vivo evaluation.Phytomedicine20195426527710.1016/j.phymed.2018.07.003 30668377
     [Google Scholar]
  50. LedónN. CasacóA. RemirezD. Effects of a mixture of fatty acids from sugar cane (Saccharum officinarum L.) wax oil in two models of inflammation: Zymosan-induced arthritis and mice tail test of psoriasis.Phytomedicine2007141069069510.1016/j.phymed.2006.12.019 17292594
     [Google Scholar]
  51. RadhaM.H. LaxmipriyaN.P. Evaluation of biological properties and clinical effectiveness of Aloe vera: A systematic review.J. Tradit. Complement. Med.201551212610.1016/j.jtcme.2014.10.006 26151005
     [Google Scholar]
  52. LengH. PuL. XuL. ShiX. JiJ. ChenK. Effects of aloe polysaccharide, a polysaccharide extracted from Aloe vera, on TNF α induced HaCaT cell proliferation and the underlying mechanism in psoriasis.Mol. Med. Rep.20181833537354310.3892/mmr.2018.9319 30066937
     [Google Scholar]
  53. LeeS.Y. NamS. HongI.K. KimH. YangH. ChoH.J. Antiproliferation of keratinocytes and alleviation of psoriasis by the ethanol extract of Artemisia capillaris.Phytother. Res.201832592393210.1002/ptr.6032 29377339
     [Google Scholar]
  54. LeeS.Y. NamS. KimS. Therapeutic efficacies of Artemisia capillaris extract cream formulation in imiquimod‐induced psoriasis models.Evid. Based Complement. Alternat. Med.201820181361049410.1155/2018/3610494 30210571
     [Google Scholar]
  55. MansouriP. MirafzalS. NajafizadehP. Safaei-NaraghiZ. Salehi-SurmaghiM.H. HashemianF. The impact of topical Saint John’s Wort (Hypericum perforatum) treatment on tissue tumor necrosis factor-alpha levels in plaque-type psoriasis.J. Postgrad. Med.201763421522010.4103/0022‑3859.201423 28272075
     [Google Scholar]
  56. ZhangH. DangM. ChenX. YanX. Rehmannia radix extract ameliorates imiquimod-induced psoriasis-like skin inflammation in a mouse model via the janus-kinase signal transducer and activator of transcription pathway.Pharmacogn. Mag.20201671
     [Google Scholar]
  57. LiuC.L. ChengL. KoC.H. Bioassay-guided isolation of anti-inflammatory components from the root of Rehmannia glutinosa and its underlying mechanism via inhibition of iNOS pathway.J. Ethnopharmacol.2012143386787510.1016/j.jep.2012.08.012 23034094
     [Google Scholar]
  58. JiaJ. MoX. LiuJ. Mechanism of danshensu-induced inhibition of abnormal epidermal proliferation in psoriasis.Eur. J. Pharmacol.202086817288110.1016/j.ejphar.2019.172881 31866405
     [Google Scholar]
  59. TangL. HeS. WangX. Cryptotanshinone reduces psoriatic epidermal hyperplasia via inhibiting the activation of STAT 3.Exp. Dermatol.201827326827510.1111/exd.13511 29427477
     [Google Scholar]
  60. MalešŽ. DrvarD.L. DukaI. ŽužulK. Application of medicinal plants in several dermatovenerological entities.Acta Pharm.201969452553110.2478/acph‑2019‑0045 31639095
     [Google Scholar]
  61. AgrawalU. GuptaM. VyasS.P. Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis.Artif. Cells Nanomed. Biotechnol.2015431333910.3109/21691401.2013.832683 24040836
     [Google Scholar]
  62. LaiC.Y. SuY.W. LinK.I. HsuL.C. ChuangT.H. Natural modulators of endosomal toll‐like receptor‐mediated psoriatic skin inflammation.J. Immunol. Res.20172017111510.1155/2017/7807313 28894754
     [Google Scholar]
  63. OliveiraA. MonteiroV. Navegantes-LimaK. Resveratrol role in autoimmune disease—a mini-review.Nutrients2017912130610.3390/nu9121306 29194364
     [Google Scholar]
  64. WuaS.T. SunaJ.C. LeebK.J. SuncY.M. Docking prediction for tumor necrosis factor-α and five herbal inhibitors.Int. J. Eng. Sci. Technol.2010242634277
     [Google Scholar]
  65. GuptaS.C. PatchvaS. AggarwalB.B. Therapeutic roles of curcumin: Lessons learned from clinical trials.AAPS J.201315119521810.1208/s12248‑012‑9432‑8 23143785
     [Google Scholar]
  66. PuticA. StecherL. PrinzH. MüllerK. Structure–activity relationship studies of acridones as potential antipsoriatic agents. 1. Synthesis and antiproliferative activity of simple N-unsubstituted 10H-acridin-9-ones against human keratinocyte growth.Eur. J. Med. Chem.20104583299331010.1016/j.ejmech.2010.04.013 20452101
     [Google Scholar]
  67. Nowak-PerlakM. SzpadelK. JabłońskaI. PizonM. WoźniakM. Promising strategies in plant-derived treatments of psoriasis-update of in vitro , in vivo , and clinical trials studies.Molecules202227359110.3390/molecules27030591 35163855
     [Google Scholar]
  68. KiekowC.J. FigueiróF. DietrichF. Quercetin derivative induces cell death in glioma cells by modulating NF-κB nuclear translocation and caspase-3 activation.Eur. J. Pharm. Sci.20168411612210.1016/j.ejps.2016.01.019 26802551
     [Google Scholar]
  69. ChenH. LuC. LiuH. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway.Int. Immunopharmacol.20174811011710.1016/j.intimp.2017.04.022 28499194
     [Google Scholar]
  70. KangH.K. EcklundD. LiuM. DattaS.K. Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells.Arthritis Res. Ther.2009112R5910.1186/ar2682 19405952
     [Google Scholar]
  71. MirzoevaS. TongX. BridgemanB.B. PlebanekM.P. VolpertO.V. Apigenin inhibits UVB-induced skin carcinogenesis: The role of thrombospondin-1 as an anti-inflammatory factor.Neoplasia201820993094210.1016/j.neo.2018.07.005 30118999
     [Google Scholar]
  72. LiuC. LiuH. LuC. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.Clin. Exp. Immunol.2019198340341510.1111/cei.13363 31407330
     [Google Scholar]
  73. WangA. WeiJ. LuC. Genistein suppresses psoriasis-related inflammation through a STAT3–NF-κB-dependent mechanism in keratinocytes.Int. Immunopharmacol.20196927027810.1016/j.intimp.2019.01.054 30743203
     [Google Scholar]
  74. SmolińskaE. MoskotM. Jakóbkiewicz-BaneckaJ. Molecular action of isoflavone genistein in the human epithelial cell line HaCaT.PLoS One2018132e019229710.1371/journal.pone.0192297 29444128
     [Google Scholar]
  75. DhanabalS.P. MurugananthamN. BasavarajK.H. WadhwaniA. ShamasundarN.M. Antipsoriatic activity of extracts and fractions obtained from Memecylon malabaricum leaves.J. Pharm. Pharmacol.201264101501150910.1111/j.2042‑7158.2012.01528.x 22943181
     [Google Scholar]
  76. VerriW.A.Jr VicentiniF.T. BaracatM.M. Flavonoids as anti-inflammatory and analgesic drugs: Mechanisms of action and perspectives in the development of pharmaceutical forms.Stud Natu Prod Chem20123629733010.1016/B978‑0‑444‑53836‑9.00026‑8
     [Google Scholar]
  77. DeenonpoeR. PrayongP. ThippamomN. MeephansanJ. Na-BangchangK. Anti-inflammatory effect of naringin and sericin combination on human peripheral blood mononuclear cells (hPBMCs) from patient with psoriasis.BMC Complement. Altern. Med.201919116810.1186/s12906‑019‑2535‑3 31291937
     [Google Scholar]
  78. ZhangS. LiuX. MeiL. WangH. FangF. Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice.BMC Complement. Altern. Med.201616133410.1186/s12906‑016‑1325‑4 27581210
     [Google Scholar]
  79. ChamcheuJ.C. PalH.C. SiddiquiI.A. Prodifferentiation, anti-inflammatory and antiproliferative effects of delphinidin, a dietary anthocyanidin, in a full-thickness three-dimensional reconstituted human skin model of psoriasis.Skin Pharmacol. Physiol.201528417718810.1159/000368445 25620035
     [Google Scholar]
  80. ShihC.M. HsiehC.K. HuangC.Y. Lycopene inhibit IMQ-induced psoriasis-like inflammation by inhibiting ICAM-1 production in mice.Polymers (Basel)2020127152110.3390/polym12071521 32659890
     [Google Scholar]
  81. SyedT.A. AhmadS.A. HoltA.H. AhmadS.A. AhmadS.H. AfzalM. Management of psoriasis with Aloe vera extract in a hydrophilic cream: A placebo‐controlled, double‐blind study.Trop. Med. Int. Health19961450550910.1046/j.1365‑3156.1996.d01‑91.x 8765459
     [Google Scholar]
  82. ChoonhakarnC. BusaracomeP. SripanidkulchaiB. SarakarnP. A prospective, randomized clinical trial comparing topical aloe vera with 0.1% triamcinolone acetonide in mild to moderate plaque psoriasis.J. Eur. Acad. Dermatol. Venereol.201024216817210.1111/j.1468‑3083.2009.03377.x 19686327
     [Google Scholar]
  83. LinY.K. ChangS.H. YangC.Y. SeeL.C. LeeB.H. ShihI.H. Efficacy and safety of indigo naturalis ointment in treating atopic dermatitis: A randomized clinical trial.J. Ethnopharmacol.202025011247710.1016/j.jep.2019.112477 31838180
     [Google Scholar]
  84. SingerE.M. NattkemperL.A. BenoitB.M. IL-31 is produced by the malignant T-cell population in cutaneous T-Cell lymphoma and correlates with CTCL pruritus.J. Invest. Dermatol.2013133122783278510.1038/jid.2013.227 23698099
     [Google Scholar]
  85. BernsteinS. DonskyH. GulliverW. HamiltonD. NobelS. NormanR. Treatment of mild to moderate psoriasis with Reliéva, a Mahonia aquifolium extract--a double-blind, placebo-controlled study.Am. J. Ther.200613212112610.1097/00045391‑200603000‑00007 16645428
     [Google Scholar]
  86. SarafianG. AfsharM. MansouriP. AsgarpanahJ. RaoufinejadK. RajabiM. Topical turmeric microemulgel in the management of plaque psoriasis; a clinical evaluation.Iran. J. Pharm. Res.2015143865876 26330875
     [Google Scholar]
  87. NajafizadehP. HashemianF. MansouriP. FarshiS. SurmaghiM.S. ChalangariR. The evaluation of the clinical effect of topical St Johns wort (Hypericum perforatum L.) in plaque type psoriasis vulgaris: A pilot study.Australas. J. Dermatol.201253213113510.1111/j.1440‑0960.2012.00877.x 22571563
     [Google Scholar]
  88. LinY-K. Oil-extracted product of indigo naturalis, and preparation process and uses thereof.US Patent 8784905B2,2014
  89. GulliverW.P. DonskyH.J. A report on three recent clinical trials using Mahonia aquifolium 10% topical cream and a review of the worldwide clinical experience with Mahonia aquifolium for the treatment of plaque psoriasis.Am. J. Ther.200512539840610.1097/01.mjt.0000174350.82270.da 16148424
     [Google Scholar]
  90. SrivastavaA. NagarH. ChandelH. RanawatM. Antipsoriatic activity of ethanolic extract of Woodfordia fruticosa (L.) Kurz flowers in a novel in vivo screening model.Indian J. Pharmacol.201648553153610.4103/0253‑7613.190740 27721539
     [Google Scholar]
  91. KromaA. PawlaczykM. Feliczak-GuzikA. Phytoecdysteroids from Serratula coronata L. for psoriatic skincare.Molecules20222711347110.3390/molecules27113471 35684408
     [Google Scholar]
  92. MiroddiM. NavarraM. CalapaiF. Review of clinical pharmacology of Aloe vera L. in the treatment of psoriasis.Phytother. Res.201529564865510.1002/ptr.5316 25756474
     [Google Scholar]
  93. WadherK. DabreS. GaidhaneA. TrivediS. UmekarM. Evaluation of antipsoriatic activity of gel containing Pongamia pinnata extract on imiquimod-induced psoriasis.Clin Phytosci2021712010.1186/s40816‑021‑00256‑6
     [Google Scholar]
  94. RamanunnyA.K. WadhwaS. Kumar SinghS. Topical non-aqueous nanoemulsion of Alpinia galanga extract for effective treatment in psoriasis: In vitro and in vivo evaluation.Int. J. Pharm.202262412188210.1016/j.ijpharm.2022.121882 35671853
     [Google Scholar]
  95. ZhaoJ. DiT. WangY. Paeoniflorin inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response and cytokine secretion.Eur. J. Pharmacol.201677213114310.1016/j.ejphar.2015.12.040 26738780
     [Google Scholar]
  96. EllisC.N. BerberianB. SulicaV.I. A double-blind evaluation of topical capsaicin in pruritic psoriasis.J. Am. Acad. Dermatol.199329343844210.1016/0190‑9622(93)70208‑B 7688774
     [Google Scholar]
  97. ZhangS. WangJ. LiuL. Efficacy and safety of curcumin in psoriasis: Preclinical and clinical evidence and possible mechanisms.Front. Pharmacol.20221390316010.3389/fphar.2022.903160 36120325
     [Google Scholar]
  98. LiP. LiY. JiangH. Glabridin, an isoflavan from licorice root, ameliorates imiquimod-induced psoriasis-like inflammation of BALB/c mice.Int. Immunopharmacol.20185924325110.1016/j.intimp.2018.04.018 29665498
     [Google Scholar]
  99. LiuC. ChenY. LuC. Betulinic acid suppresses Th17 response and ameliorates psoriasis-like murine skin inflammation.Int. Immunopharmacol.20197334335210.1016/j.intimp.2019.05.030 31129421
     [Google Scholar]
  100. TogniS. MaramaldiG. Di PierroF. BiondiM. A cosmeceutical formulation based on boswellic acids for the treatment of erythematous eczema and psoriasis.Clin. Cosmet. Investig. Dermatol.20147321327 25419153
     [Google Scholar]
  101. XieJ. HuangS. HuangH. Advances in the application of natural products and the novel drug delivery systems for psoriasis.Front. Pharmacol.20211264495210.3389/fphar.2021.644952 33967781
     [Google Scholar]
  102. NguyenL.T.H. Signaling pathways and targets of natural products in psoriasis treatment.Explor. Med.20223434536710.37349/emed.2022.00098
     [Google Scholar]
  103. KushwahaP. SaxenaS. ShuklaB. A recent overview on dermatological applications of liposomes.Recent Pat. Nanotechnol.202115431032110.2174/1872210514666201021145233 33087038
     [Google Scholar]
  104. IzharM.P. HafeezA. KushwahaP. Simrah. Drug delivery through niosomes: A comprehensive review with therapeutic applications.J. Cluster Sci.20233452257227310.1007/s10876‑023‑02423‑w
     [Google Scholar]
  105. JahanA. AkhtarJ. Badruddeen, Jaiswal N, Ali A, Ahmad U. Recapitulate genistein for topical applications including nanotechnology delivery.Inorg Nano-Metal Chem20225291306131710.1080/24701556.2022.2048021
     [Google Scholar]
  106. SiddiquiZ. KhanM.I. AkhtarJ. AhmadM. Multifunctional role of Phyllanthus acidus L. as a therapeutic agent for management of diabetes and associated complications: A review.Biomed. Pharmacol. J.20221541821183110.13005/bpj/2520
     [Google Scholar]
  107. MishraS.K. TiwariS. ShrivastavaS. Pharmacological evaluation of the efficacy of Dysoxylum binectariferum stem bark and its active constituent rohitukine in regulation of dyslipidemia in rats.J. Nat. Med.201872483784510.1007/s11418‑014‑0830‑3 24677095
     [Google Scholar]
  108. HuangT.H. LinC.F. AlalaiweA. YangS.C. FangJ.Y. Apoptotic or antiproliferative activity of natural products against keratinocytes for the treatment of psoriasis.Int. J. Mol. Sci.20192010255810.3390/ijms20102558 31137673
     [Google Scholar]
  109. BahrainiP. RajabiM. MansouriP. SarafianG. ChalangariR. AzizianZ. Turmeric tonic as a treatment in scalp psoriasis: A randomized placebo‐control clinical trial.J. Cosmet. Dermatol.201817346146610.1111/jocd.12513 29607625
     [Google Scholar]
  110. ZorkoM.S. ŠtrukeljB. ŠvajgerU. KreftS. LunderT. Efficacy of a polyphenolic extract from silver fir (Abies alba) bark on psoriasis: a randomised, double-blind, placebo-controlled trial.Pharmazie20187315660 29441952
     [Google Scholar]
  111. YuC. FanX. LiZ. LiuX. WangG. Efficacy and safety of total glucosides of paeony combined with acitretin in the treatment of moderate-to-severe plaque psoriasis: A double-blind, randomised, placebo-controlled trial.Eur. J. Dermatol.201727215015410.1684/ejd.2016.2946 28400341
     [Google Scholar]
  112. GonçalvesG.M.S. WenceslauL.R. MendonçaJ.A. The use of medicinal plants for the treatment of psoriasis: A systematic review and meta-analysis.Indian J. Dermatol. Venereol. Leprol.202289454354810.25259/IJDVL_46_2022 36461795
     [Google Scholar]
  113. LeeH.J. KimM. Challenges and future trends in the treatment of psoriasis.Int. J. Mol. Sci.202324171331310.3390/ijms241713313 37686119
     [Google Scholar]
/content/journals/cff/10.2174/0126668629317880250219052526
Loading
Promising Herbal Strategies in the Treatment of Psoriasis
Curr Func Foods 4, e26668629317880 (2026); https://doi.org/10.2174/0126668629317880250219052526
/content/journals/cff/10.2174/0126668629317880250219052526
/content/journals/cff/10.2174/0126668629317880250219052526
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): bioactives; clinical trial; Herbal extract; psoriasis; skin melanoma; synthetic drugs

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test